Country Profile

Nicaragua

Nicaragua is an emerging destination for Indian pharmaceutical exports — $27.1M in FY 2025–26, with 2.7× growth over the past decade. Medicines accounts for 67% of shipments, with vaccines contributing $5.67M. The compound annual growth rate since FY2015 stands at 9.3%.

🇳🇮 $27.1M · 2.7× growth since FY2015 · 9.3% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$27.1M
Exports FY2025–26 DGCIS
2.7×
Growth FY2015→2026
9.3%
CAGR FY2015→2026
67%
Medicines Share
5
Product Categories Supplied
Nicaragua is an emerging destination for Indian pharmaceutical exports — $27.1M in FY 2025–26, with 2.7× growth over the past decade. Medicines accounts for 67% of shipments, with vaccines contributing $5.67M. The compound annual growth rate since FY2015 stands at 9.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $18.2M (66.9%) Vaccines $5.67M (20.9%) Surgical & Hospital Supplies $2.04M (7.5%) Medicine Ingredients $1.08M (4.0%) Traditional & Herbal $186K (0.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Nicaragua in the RBI overseas direct investment dataset (2011–2026).